Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial
Daiichi Sankyo
Koichi Goto; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert F Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Chih-Hsi Kuo; James Chih-Hsin Yang; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Wenqin Feng; Zenta Tsuchihashi; Pasi A Jänne